USPTO serial 79272459
QUIAPEG PHARMACEUTICALS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 27, 2022
- Examiner
- CROWLEY, SEAN MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with QUIAPEG PHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cynthia Johnson Walden
Cynthia Johnson Walden Fish & Richardson P.C.P.O. Box 1022Minneapolis, MN 55440-1022UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Regents for use in industry and science, namely, reagents for use with a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; cross linking agents being industrial chemicals for use in industry and science; polyethylene glycols for use in industry and science; chemical structures being industrial chemicals, namely, phosphotriester linkers | ACTIVE | — |
| 005 | Pharmaceuticals, medical and veterinary preparations for the treatment of cancer, cardiovascular disease, respiratory disorders, metabolic disorders, autoimmune disease, neurologic and psychiatric disorders and infectious disease derived from PEGylation technologies; pharmaceutical preparations, namely, a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; pharmaceutical, medical and veterinary substances | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis, testing and development in the field of pharmaceuticals, of pharmaceutical, medical and veterinary preparations and substances derived from PEGylation technologies; PEGylation pharmaceuticals research services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by QuiaPEG Pharmaceuticals AB
- Other trademarks owned by QuiaPEG Pharmaceuticals AB
- Other trademarks owned by QuiaPEG Pharmaceuticals AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named QUIAPEG PHARMACEUTICALS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 23, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 6, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 18, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 18, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 27, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 27, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 27, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 12, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 12, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 12, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 22, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 22, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 22, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 3, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 3, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 3, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 3, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 3, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 10, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 21, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 21, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 1, 2020 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Aug 4, 2020 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Aug 4, 2020 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Jul 17, 2020 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jul 14, 2020 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 1, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 1, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 1, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 1, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 1, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 28, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 28, 2020 | ALIE | ASSIGNED TO LIE | — |
| May 21, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 7, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 14, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 14, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 22, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 21, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 5, 2019 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Dec 5, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 4, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 4, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 29, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 25, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 21, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |